VRTX  valuation analysis

Basics
Name: Vertex Pharmaceuticals Incorporated
Description: Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 05, 2022
Market cap: $69.85B (112th)
Sales(TTM): $7.95B (379th)
Earnings(TTM): $2.45B (158th)

Value
FFER: 1.64 (why)
Actual price: $270.84
FFEThis is Vertex Pharmaceuticals Incorporated's the estimated price. FFEs are the denominator of the FFER ratio.: $164.88
Quantile: VRTX is expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry
Sales / MarketCap
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry
Book / MarketCap
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry
Equity / Assets
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry